Cosmos Health Inc.
COSM- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001474167
No open-market purchases or sales by Cosmos Health Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q3 2026, worth $3.20M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 19, 2026
- $14.4M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +10 vs. previous quarter
- 30
- 13F valueReported value at the end of Q3 2026
- $3.20M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $65.3M
- +19.9% year over year
- Net income, FY2025
- -$19.1M
- No comparable prior period
- Free cash flow, FY2025
- -$8.50M
- No comparable prior period
- Revenue, Q2 FY2026
- $19.0M
- +28.8% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $19.1M (29.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.77M
- Shares sold short
- Change
- −511.7K
- −22.4% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding COSM, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding COSM at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Cosmos Health Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 (view filing)11:52 AM ET | Jul 30 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +349.8K | $0.2001 | +$70.0K | +2.5%14.6M after | |
| Jul 30, 2026 (view filing)11:09 AM ET | Jul 29 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +766.3K | $0.1827 | +$140.0K | +5.7%14.2M after | |
| Jun 17, 2026 (view filing)9:15 AM ET | Jun 16 | 1 day | Terzis GeorgiosChief Financial Officer | PPurchaseCommon Stock, par value $.001 | +168.1K | $0.2498 | +$42.0K | +8.1%2.24M after | |
| Jun 12, 2026 (view filing)1:22 PM ET | Jun 11 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +218.4K | $0.206 | +$45.0K | +1.6%13.5M after | |
| Jun 12, 2026 (view filing)6:20 AM ET | Jun 10 | 2 days | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +701.4K | $0.2281 | +$160.0K | +5.6%13.3M after | |
| Feb 13, 2026 (view filing)10:05 AM ET | Feb 12 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +388.5K | $0.3732 | +$145.0K | +4.6%8.86M after | |
| Feb 12, 2026 (view filing)2:20 PM ET | Feb 11 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +291.3K | $0.412 | +$120.0K | +3.6%8.47M after | |
| Jan 26, 2026 (view filing) | Jan 23 | 3 days | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +90.3K | $0.50 | +$45.2K | +1.1%8.18M after | |
| Jan 21, 2026 (view filing) | Jan 20 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +353.3K | $0.50 | +$176.7K | +4.6%8.09M after | |
| Jan 15, 2026 (view filing)9:40 AM ET | Jan 14 | 1 day | Siokas GrigoriosChief Executive Officer | PPurchaseCommon Stock, par value $.001 | +493.5K | $0.4458 | +$220.0K | +6.8%7.74M after |
Top 10 13F holders, Q3 2026
See all 30 holdersThe largest institutional positions in Cosmos Health Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 5,119,640 | $2.20M | 0.00% | +5,119,600+12,799,000.0% | Added |
| Geode Capital Management, LLC | 405,390 | $174.3K | 0.00% | +123,296+43.7% | Added |
| UBS Group AG | 352,799 | $151.7K | 0.00% | −241,663−40.7% | Reduced |
| Vanguard Capital Management LLC | 304,117 | $130.8K | 0.00% | +130,151+74.8% | Added |
| BlackRock, Inc. | 267,797 | $115.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 148,175 | $63.7K | 0.00% | −185,667−55.6% | Reduced |
| Susquehanna International Group, LLP | 138,280 | $59.4K | 0.00% | +138,280 | New |
| Citigroup Inc | 113,138 | $48.6K | 0.00% | +113,095+263,011.6% | Added |
| Virtu Financial LLC | 111,609 | $48.0K | 0.00% | +111,609 | New |
| XTX Topco Ltd | 80,329 | $34.5K | 0.00% | +80,329 | New |
Holders of 5% or more of COSM
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Cosmos Health Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Siokas Grigorios | 13D/A | 22.90%6.87M shares | +6.30 ppfrom 16.60% | Feb 12, 20219 filings | May 27, 2025 | SEC |
| Bovopoulos Andreas | 13G/A | 10.00%3.73M shares | – | Mar 10, 20261 filing | Mar 10, 2026 | SEC |
| Bovopoulos Andreas | 13G/A | 8.10%8.12M shares | +1.20 ppfrom 6.90% | Mar 6, 20257 filings | Nov 12, 2026 | SEC |
| Wells Fargo & Company | 13G | 5.10%5.12M shares | New | Oct 29, 20261 filing | Oct 29, 2026 | SEC |